← FDA DRUG APPROVALS

FDA ANDA · ANDA040555

PHENTERMINE HYDROCHLORIDE

Sponsor: LANNETT

APPLICATION
ANDA040555
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-15
LATEST ACTION
2017-05-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PHENTERMINE HYDROCHLORIDEDiscontinued
PHENTERMINE HYDROCHLORIDE 37.5MG · TABLET · ORAL

Approval history

2017-05-31Labeling · Supplement 16 · standardAP
2012-12-05Labeling · Supplement 10 · standardAP
2012-04-27Labeling · Supplement 9AP
2011-08-22Manufacturing (CMC) · Supplement 8AP
2005-04-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →